Target intelligence / Profile preview

Arginyl aminopeptidase-like 1 (RNPEPL1)

Target
RNPEPL1
Molecular classification
Enzyme, Metalloaminopeptidase, M1 family of zinc metallopeptidases
01

Overview

Arginyl aminopeptidase-like 1 (RNPEPL1) is a broad specificity metalloaminopeptidase and member of the M1 family of zinc metallopeptidases that preferentially hydrolyzes N-terminal methionine, citrulline, or glutamine residues from peptides. RNPEPL1 is ubiquitously expressed across human tissues and displays a broad range of enzymatic activity, with highest activity at neutral to slightly alkaline pH. The enzyme has similarities to leukotriene A4 hydrolase and clusters phylogenetically with proteins involved in inflammation, though its biological role remains incompletely defined; evidence suggests a modest decrease in expression during inflammatory responses. No approved therapeutic agents target RNPEPL1, and its involvement in human diseases remains under investigation.

Other names
Aminopeptidase RNPEPL1Methionyl aminopeptidaseAminopeptidase B-like 1Argininyl aminopeptidase-like 1RNPEP-like 1Arginyl aminopeptidase (aminopeptidase B)-like 1
02

Biological functions

Proteolysis (cleavage of peptide bonds at the N-terminus)Hydrolyzes N-terminal methionine, citrulline, or glutaminePotential role in inflammation
03

Disease associations

Other (RNPEPL1 expression links to inflammation; association with venous hemangioma and brachydactyly reported, but not well characterized in major therapeutic areas)

Beyond the preview

Go deeper on Arginyl aminopeptidase-like 1 (RNPEPL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arginyl aminopeptidase-like 1 (RNPEPL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call